This Biogen Analyst Turns Bullish; Here Are Top 3 Upgrades For Monday
Avi Kapoor 4 months ago
NewsUpgradesAnalyst RatingsTrading Ideas
Top Wall Street analysts upgraded Biogen Inc. and Cognizant Technology Solutions, see analyst ratings page for full changes and other stock views.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Needham analyst Ami Fadia upgraded Biogen Inc. (NASDAQ:BIIB) from Hold to Buy and announced a $255 price target. Biogen shares closed at $195.34 on Friday. See how other analysts view this stock.
- Wedbush analyst Steven Wahrhaftig upgraded Cognizant Technology Solutions Corporation (NASDAQ:CTSH) from Neutral to Outperform and boosted the price target from $56 to $70. Cognizant Tech shares closed at $53.21 on Friday. See how other analysts view this stock.
- Barclays analyst Dan Levy upgraded Avis Budget Group, Inc. (NASDAQ:CAR) from Underweight to Equal-Weight and raised the price target from $140 to $160. Avis Budget shares closed at $176.79 on Friday.
Considering buying BIIB stock? Here’s what analysts think:
Photo via Shutterstock